Ariyoshi Y - Search Results

1

Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.

Kunikane H, Watanabe K, Fukuoka M, Saijo N, Furuse K, Ikegami H, Ariyoshi Y, Kishimoto S. Kunikane H, et al. Among authors: ariyoshi y. Int J Clin Oncol. 2001 Dec;6(6):296-301. doi: 10.1007/s10147-001-8031-y. Int J Clin Oncol. 2001. PMID: 11828949 Clinical Trial.

2

Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.

Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K. Ariyoshi Y, et al. Jpn J Clin Oncol. 1994 Oct;24(5):275-81. Jpn J Clin Oncol. 1994. PMID: 7967106 Clinical Trial.

3

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.

Kudoh S, Fujiwara Y, Takada Y, Yamamoto H, Kinoshita A, Ariyoshi Y, Furuse K, Fukuoka M. Kudoh S, et al. Among authors: ariyoshi y. J Clin Oncol. 1998 Mar;16(3):1068-74. doi: 10.1200/JCO.1998.16.3.1068. J Clin Oncol. 1998. PMID: 9508192 Clinical Trial.

4

Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.

Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N. Furuse K, et al. Among authors: ariyoshi y. J Clin Oncol. 1998 Jun;16(6):2126-32. doi: 10.1200/JCO.1998.16.6.2126. J Clin Oncol. 1998. PMID: 9626212 Clinical Trial.

5

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y. Furuse K, et al. Among authors: ariyoshi y. J Clin Oncol. 1999 Sep;17(9):2692-9. doi: 10.1200/JCO.1999.17.9.2692. J Clin Oncol. 1999. PMID: 10561343 Clinical Trial.

6

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.

Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, Kurita Y, Saijo N. Kubota K, et al. Among authors: ariyoshi y. Ann Oncol. 2000 Apr;11(4):445-50. doi: 10.1023/a:1008328207137. Ann Oncol. 2000. PMID: 10847464 Free article. Clinical Trial.

7

Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).

Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y. Nishimura Y, et al. Among authors: ariyoshi y. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):786-92. doi: 10.1016/j.ijrobp.2007.04.008. Epub 2007 May 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17512126 Clinical Trial.

8

Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.

Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, Takada M, Fukuoka M, Ariyoshi Y, Fukuda H, Saijo N. Yoshida K, et al. Among authors: ariyoshi y. Lung Cancer. 2007 Dec;58(3):362-8. doi: 10.1016/j.lungcan.2007.07.009. Epub 2007 Aug 22. Lung Cancer. 2007. PMID: 17716779 Clinical Trial.

9

A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.

Kubota K, Sakai H, Yamamoto N, Kunitoh H, Nakagawa K, Takeda K, Ichinose Y, Saijo N, Ariyoshi Y, Fukuoka M. Kubota K, et al. Among authors: ariyoshi y. J Thorac Oncol. 2010 May;5(5):702-6. doi: 10.1097/JTO.0b013e3181ce3e22. J Thorac Oncol. 2010. PMID: 20150827 Free article. Clinical Trial.

10

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.

Sugiura T, Ariyoshi Y, Negoro S, Nakamura S, Ikegami H, Takada M, Yana T, Fukuoka M. Sugiura T, et al. Among authors: ariyoshi y. Invest New Drugs. 2005 Aug;23(4):331-7. doi: 10.1007/s10637-005-1441-3. Invest New Drugs. 2005. PMID: 16012792 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters